CVS faces significant 2025 headwinds, including intense pharmacy competition, threatened new federal government pressures, ...

The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...

CVS faces strong competition from Amazon, Walmart, and Costco, impacting market share. Read why I maintain a Hold rating for ...

We recently published a list of 12 Best Fortune 500 Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

The latest report builds on a study the agency published in July, which found that PBMs inflated drug prices at the expense of pharmacies and patients. It found that pharmacies associated with ...

Analysts have recently evaluated CVS Health and provided 12-month price targets. The average target is $68.07, accompanied by ...

Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.

We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at ...

The pharmaceutical landscape enters 2025 with a mix of challenges and opportunities, with the potential to shape the future ...

As the director, he represents Snyders Pharmacy’s fourth generation. The 95-year-old chain spans the stateline from Oregon to ...

CVS Pharmacy Inc. is being sued by the U.S. Department ... In a statement emailed to USA TODAY, a CVS spokesperson said, "We have cooperated with the DOJ’s investigation for more than four ...